510(k) · Cleared
ClearedDimension C3 Flex Reagent Cartridge
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dade Behring, Inc. · CZW Complement C3, Antigen, Antiserum, Control
Cleared on Mar 1, 2000 as substantially equivalent to K780913 (Beckman Instruments, Inc., 1978) and 1 other predicate after a 71-day review. Its family tree reaches back 1 generation to 1978.
- Decided
- Mar 1, 2000
- Review
- 71 days
- Class
- Class II
- Product code
- CZW
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K780913 (1978). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK780913 Additional Reagents Kits for Imm. SystemBeckman Instruments, Inc. · 1978
- This deviceK994296 Dimension C3 Flex Reagent CartridgeDade Behring, Inc. · 2000
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K780913 | Additional Reagents Kits for Imm. System | Beckman Instruments, Inc. | 1978 | — |
| 0 (this device) | K994296 | Dimension C3 Flex Reagent Cartridge | Dade Behring, Inc. | 2000 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1992 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CZW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K780913 | Additional Reagents Kits for Imm. SystemSummary page 1…e of Product: C3 Flex® Reagent Cartridge FDA Classification Name: Complement C3, Antigen, Antiserum, Control; 82CZW Predicate Device: Beckman Array® Complement C3 Assay (K780913; K922273) Device Description: The C3 Flex® reagent cartridge for the Dimension® clinical chemistry system is a quantitative, tur… | 1978 |
| * | K922273 | Array (R) 360Summary page 1…uct: C3 Flex® Reagent Cartridge FDA Classification Name: Complement C3, Antigen, Antiserum, Control; 82CZW Predicate Device: Beckman Array® Complement C3 Assay (K780913; K922273) Device Description: The C3 Flex® reagent cartridge for the Dimension® clinical chemistry system is a quantitative, turbidimetri… | 1992 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
- 6 other devices also cite its predicate K780913.
How does its category compare?
All CZW devicesCZW Complement C3, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CZW
1in 2010
2026 to Oct 25, outlined.
Median 510(k) review, days · CZW
Too few CZW 510(k)s in any year since 2007 to give a median.
Recalls per year · CZW
No recall names CZW since 2007.
Adverse event reports per year · CZW
2in 2024
MAUDE reports naming product code CZW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 1 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The C3 Flex® reagent cartridge for the Dimension® clinical chemistry system is an in vitro diagnostic test intended to quantitatively measure complement C3 (C3) in serum as an aid in the diagnosis of immunologic disorders associated with complement C3 protein.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K994296 · printed Nov 6, 2026
Cite this page
510(k) Report. “K994296: Dimension C3 Flex Reagent Cartridge.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K994296
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026